Colorectal cancers are commonly treated by surgical means. While histopathology aids the staging of cancer, not all are addressed by surgical intervention but also, by chemotherapies; the benefits of which are yet to be specifically allocated to each stage. Here is a ‘Journal Watch’ summarizing the study titled “Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer” , published in the The New England Journal of Medicine, 2022. Authors: Tie J, Cohen JD, Lahouel K, Lo SN, Wang Y, Kosmider S, Wong R, Shapiro J, Lee M, Harris S, Khattak A, Burge M, et al. Swipe through to know the findings!
To download the pdf, click here! Would you practice ctDNA-guided approach before administering adjuvant chemotherapy in colon cancer patients? You may also want to read - Avelumab + Axitinib vs. Sunitinib in Elderly Patients with aRCC: Extended Follow-up JAVELIN…
